Quantcast
Last updated on April 18, 2014 at 15:02 EDT

Latest Veronica Galvan Stories

2010-04-02 09:18:04

Rapamycin proves mettle in second model of memory-robbing disease If research results continue to be repeated and are turned into clinical trials, a drug already approved for some uses could be marshaled "” sooner than we expect "” to prevent Alzheimer's disease in humans and improve health to the end of life. A few weeks after a report that rapamycin, a drug that extends lifespan in mice and that is currently used in transplant patients, curbed the effects of Alzheimer's disease...